Results 151 to 160 of about 3,791 (194)

Kongenitale Tränenwegsobstruktionen

Klinische Monatsblätter für Augenheilkunde, 1990
If typical congenital nasolacrimal obstruction symptoms occur during the first few days of life immediate treatment is necessary. At the latest within two weeks the benefits of medication and massages of the lacrimal sac should be exploited to treat these conditions.
Heiligenhaus A, Laffers Z
openaire   +3 more sources

Dacryoendoscopy for Lacrimal Duct Obstruction Manifesting In Childhood

Journal of Clinical & Experimental Ophthalmology, 2015
Purpose: To evaluate the results of dacryoendoscopy as a diagnostic and therapeutic option for lacrimal duct obstruction manifesting in childhood. Methods: Retrospective, non-comparative analysis of 50 dacryoendoscopies performed on 43 eyes of 35 children. All children have had lacrimal surgery (probing and/or intubation) at least twice before.
Stuhltraeger U   +3 more
openaire   +2 more sources

Dilatation and stenting for naso‐lacrimal duct obstruction, A pilot project

Acta Ophthalmologica Scandinavica, 1999
Obstruction of the naso-lacrimal duct has traditionally been treated by dacryocystorhinostomy. This pilot project aimed to evaluate the use of stents as an alternative approach to the treatment of naso-lacrimal duct obstruction.Six patients with naso-lacrimal duct obstruction underwent a pre-procedural dacryocystogram to confirm the site of obstruction.
J. Shankar, P. Walsh, S. R. Gupta
openaire   +3 more sources

Tränenwegsstenosen im Erwachsenenalter

Augenheilkunde up2date, 2020
ZusammenfassungZur Aufrechterhaltung der okulären Oberflächenhomöostase und damit den Erhalt der optischen Eigenschaften sind Tränenproduktion, -verteilung und -abtransport essenzielle physiologische Funktionen.
Hans-Gert Struck, Jens Heichel
openaire   +4 more sources

Primary Acquired Nasolacrimal Duct Obstruction (PANDO) and Secondary Acquired Lacrimal Duct Obstructions (SALDO)

2014
Epiphora resulting from nasolacrimal duct obstruction (NLDO) is common and accounts for about one-third of cases [1]. Symptomatic acquired NLDO has an average annual incidence rate of 30.47 per 100,000 [2]. It is commonly encountered in ophthalmic clinics especially ophthalmic plastics and dacryology clinics.
Saurabh Kamal, Mohammad Javed Ali
openaire   +2 more sources

Nasolacrimal Duct Obstruction and Lacrimal Surgery in Cancer Patients

2010
Nasolacrimal duct obstruction is often seen in patients with cancer. Iatrogenic causes such as surgery, radiation therapy, and chemotherapy are among the most common causes. Primary lacrimal drainage tumors are less common causes. The evaluation of patients with suspected nasolacrimal duct obstruction should include a thorough history and a ...
Aaron Savar, Bita Esmaeli
openaire   +2 more sources

Home - About - Disclaimer - Privacy